Xu Jinming, Ni Heng, Wu Yihe, Cao Jinlin, Han Xingpeng, Liu Lunxu, Fu Xiangning, Li Yin, Li Xiaofei, Xu Lin, Liu Yang, Zhao Heng, Liu Deruo, Peng Xin, Hu Jian
Department of Thoracic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Department of Thoracic Surgery, Tianjin Chest Hospital, Tianjin, China.
Transl Lung Cancer Res. 2021 Jan;10(1):402-414. doi: 10.21037/tlcr-20-1132.
Compared with open surgery, video-assisted thoracic surgery (VATS) has innovated the concept of the minimally invasive approach for non-small cell lung cancer (NSCLC) patients in past decades. This present study aimed to compare the perioperative and lymph node dissection outcomes between VATS lobectomy and open lobectomy for pathological stage T1 (pT1) NSCLC patients from both surgical and oncologic perspectives.
This was a retrospective multicenter study. Patients who underwent surgical resection for pT1 NSCLC between January 2014 and September 2017 were retrospectively reviewed from 10 thoracic surgery centers in China. Perioperative and lymph node dissection outcomes of pT1 NSCLC patients who accepted VATS or open lobectomies were compared by propensity score matching (PSM) analysis.
Of the 11,360 patients who underwent surgery for pT1 NSCLC, 7,726 were enrolled based on the selection criteria, including 1,222 cases of open lobectomies and 6,504 cases of VATS lobectomies. PSM resulted in 1,184 cases of open lobectomies and 1,184 cases of VATS lobectomies being well matched by common prognostic variables, including age, sex, and surgical side. VATS lobectomy led to better perioperative outcomes, including less blood loss (133.5±200.1 233.3±318.4, P<0.001), lower blood transfusion rate (2.4% 6.4%, P<0.001), shorter postoperative hospital stay (8.6±5.7 10.1±5.1, P<0.001), less chest drainage volume (1,109.5±854.0 1,324.1±948.8, P<0.001), and less postoperative complications (4.9% 8.2%, P<0.001). However, open lobectomy had better lymph node dissection outcomes than VATS, with increased lymph node dissection numbers (16.1±9.4 13.7±7.7, P<0.001) and more positive lymph nodes being dissected (1.5±3.9 1.1±2.5, P=0.002). Compared with VATS, open lobectomy harvested more lymph node stations (5.5±1.9 5.2±1.8, P=0.001), including more pathological N2 (pN2) lymph node stations (3.4±1.4 3.1±1.3, P<0.001).
VATS lobectomy was associated with better perioperative outcomes, such as less blood loss, lower blood transfusion rate, shorter postoperative hospital stay, less chest drainage volume and less postoperative complications. Open lobectomy has improved lymph node dissection outcomes, as more lymph nodes and positive lymph nodes were dissected for pT1 NSCLC patients during surgery.
在过去几十年中,与开胸手术相比,电视辅助胸腔镜手术(VATS)革新了非小细胞肺癌(NSCLC)患者的微创治疗理念。本研究旨在从手术和肿瘤学角度比较VATS肺叶切除术和开胸肺叶切除术治疗病理分期为T1(pT1)的NSCLC患者的围手术期及淋巴结清扫结果。
这是一项回顾性多中心研究。对2014年1月至2017年9月间在中国10个胸外科中心接受pT1 NSCLC手术切除的患者进行回顾性分析。通过倾向评分匹配(PSM)分析比较接受VATS或开胸肺叶切除术的pT1 NSCLC患者的围手术期及淋巴结清扫结果。
在11360例行pT1 NSCLC手术的患者中,根据入选标准纳入7726例,包括1222例开胸肺叶切除术和6504例VATS肺叶切除术。PSM使1184例开胸肺叶切除术和1184例VATS肺叶切除术在年龄、性别和手术侧等常见预后变量上良好匹配。VATS肺叶切除术导致更好的围手术期结果,包括失血更少(133.5±200.1对233.3±318.4,P<0.001)、输血率更低(2.4%对6.4%,P<0.001)、术后住院时间更短(8.6±5.7对10.1±5.1,P<0.001)、胸腔引流量更少(1109.5±854.0对1324.1±948.8,P<0.001)以及术后并发症更少(4.9%对8.2%,P<0.001)。然而,开胸肺叶切除术的淋巴结清扫结果优于VATS,淋巴结清扫数量增加(16.1±9.4对13.7±7.7,P<0.001),且清扫出的阳性淋巴结更多(1.5±3.9对1.1±2.5,P=0.002)。与VATS相比,开胸肺叶切除术清扫的淋巴结站数更多(5.5±1.9对5.2±1.8,P=0.001),包括更多的病理N2(pN2)淋巴结站(3.4±1.4对3.1±1.3,P<0.001)。
VATS肺叶切除术与更好的围手术期结果相关,如失血更少、输血率更低、术后住院时间更短、胸腔引流量更少以及术后并发症更少。开胸肺叶切除术改善了淋巴结清扫结果,因为在手术中为pT1 NSCLC患者清扫了更多的淋巴结和阳性淋巴结。